Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GOOS
1451
PUT
Canada Goose Holdings
GOOS
$846M
| $28.4M | 0.01% |
1,577,700
+1,364,100
| +639% | +$28.8M |
|
1452
PUT
Agilent Technologies
A
$41.9B
| $28.3M | 0.01% |
238,500
+109,500
| +85% | +$13.5M |
|
1453
CALL
Lumen
LUMN
$6.7B
| $28.3M | 0.01% |
2,593,800
+1,293,700
| +100% | +$14.5M |
|
1454
PepsiCo
PEP
$193B
| $28.3M | 0.01% |
169,697
-286,536
| -63% | -$48.2M |
|
1455
CALL
T. Rowe Price
TROW
$23.5B
| $28.3M | 0.01% |
248,700
+144,400
| +138% | +$18.4M |
|
1456
Celldex Therapeutics
CLDX
$3.26B
| $28.1M | 0.01% |
1,044,027
-91,086
| -8% | -$2.65M |
|
1457
PUT
Public Storage
PSA
$61.2B
| $28.1M | 0.01% |
90,000
+37,800
| +72% | +$13.1M |
|
1458
PUT
Microchip Technology
MCHP
$42B
| $28.1M | 0.01% |
484,400
-120,400
| -20% | -$7.97M |
|
1459
CALL
HP
HPQ
$27.9B
| $28.1M | 0.01% |
856,700
+67,400
| +9% | +$2.47M |
|
1460
Kimberly-Clark
KMB
$36.9B
| $28.1M | 0.01% |
207,727
-28,284
| -12% | -$3.73M |
|
1461
PUT
Robinhood
HOOD
$87.3B
| $28M | 0.01% |
3,408,800
+505,500
| +17% | +$4.93M |
|
1462
PUT
Royal Bank of Canada
RY
$299B
| $28M | 0.01% |
289,300
+39,000
| +16% | +$3.99M |
|
1463
Steven Madden
SHOO
$3.47B
| $28M | 0.01% |
868,907
+71,684
| +9% | +$2.72M |
|
|
ABMD
1464
DELISTED
Abiomed Inc
ABMD
| $27.9M | 0.01% |
112,830
+106,518
| +1,688% | +$28.7M |
|
1465
Iovance Biotherapeutics
IOVA
$2.93B
| $27.8M | 0.01% |
2,521,824
+2,386,618
| +1,765% | +$31.3M |
|
1466
CALL
Pool Corp
POOL
$7.24B
| $27.8M | 0.01% |
79,100
+9,500
| +14% | +$3.77M |
|
|
CANO
1467
DELISTED
Cano Health, Inc.
CANO
| $27.8M | 0.01% |
63,414
+12,982
| +26% | +$6.77M |
|
1468
PUT
Fair Isaac
FICO
$23.5B
| $27.7M | 0.01% |
69,200
+31,800
| +85% | +$12.5M |
|
|
HIMX
1469
PUT
Himax Technologies
HIMX
$2.56B
| $27.7M | 0.01% |
3,706,800
+3,061,600
| +475% | +$28.2M |
|
|
CTLT
1470
PUT
DELISTED
CATALENT, INC.
CTLT
| $27.7M | 0.01% |
258,300
+240,900
| +1,384% | +$24.5M |
|
1471
Duolingo
DUOL
$6.25B
| $27.7M | 0.01% |
316,066
+244,898
| +344% | +$21.6M |
|
1472
STMicroelectronics
STM
$48.2B
| $27.7M | 0.01% |
878,983
+773,788
| +736% | +$28.9M |
|
1473
PUT
Trump Media & Technology Group
DJT
$2.33B
| $27.6M | 0.01% |
1,143,000
-141,100
| -11% | -$5.89M |
|
1474
CALL
Synaptics
SYNA
$4.21B
| $27.6M | 0.01% |
233,900
+98,000
| +72% | +$14.4M |
|
1475
Deutsche Bank
DB
$72.4B
| $27.6M | 0.01% |
3,155,729
-1,088,829
| -26% | -$11.6M |
|
Similar funds
Citadel Advisors's Q2 2022 Portfolio in Review
As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
- Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.